Loading...
ARPA-H-SOL-26-152
Response Deadline
Jun 22, 2026, 9:00 PM(EDT)46 days
Eligibility
Contract Type
Solicitation
May 6, 2026 - Amendment 2 to STOMP ISO ARPA-H-SOL-26-152. This amendment incorporates the following changes:
1. Corrects a typo under Figure 4: TA1.2 metrics, from 50 µm to 50 nm.
2. Section B. Cost and Pricing Data Support under page 46 has been revised. The requirements that have been removed are only necessary if proposers are selected for negotiations.
All other terms and conditions remain unchanged.
____________________________________________________________
April 20, 2026 - Amendment 1 to STOMP ISO ARPA-H-SOL-26-152
This amendment corrects the Figure number on Page 11 and incorporates Figure 6 on Page 15.
_____________________________________________________________________
All questions submitted to the ISO will be compiled and addressed. Responses will be posted to the STOMP Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQ page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/stomp/faqs
_____________________________________________________________________
The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the Systematic Targeting Of MicroPlastics (STOMP) Program. ARPA-H anticipates multiple Other Transaction (OT) Agreements will result from this announcement. Interested parties are invited to review the STOMP_ISO_ARPA-H-SOL-26-152 and assciated attachments.
Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-150, for information regarding the STOMP Proposers’ Day. Special Notice (SN), ARPA-H-SN-26-150, is an independent announcement and is not attached to this ISO announcement.
The STOMP Team
DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
1301 K Street NW
Suite 1200 West
Washington, DC, 20005
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Set-Aside
No Set aside used